We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CHMP Recommends Eight Drugs at June Meeting, Including a Triple-Drug CF Therapy
CHMP Recommends Eight Drugs at June Meeting, Including a Triple-Drug CF Therapy
The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended eight drugs for approval, including Vertex Pharmaceuticals’ triple combination therapy for treatment of cystic fibrosis.